US equities |
SPCX $167.66 ▲+5.47% NVDA $236.57 ▲+1.12% MU $1,067.86 ▼-0.65% TSLA $378.78 ▲+2.21% MSFT $526.25 ▲+1.68% SNDK $1,710.80 ▼-0.53% INTC $117.16 ▼-1.82% META $744.85 ▲+2.30%
FinancialContent

Articles published by PMGC Holdings Inc.

< Previous 1 2 3 Next >
News headline image
PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB TCRT
News headline image
Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Inc. Announces Filing of Quarterly Report on Form 10-Q
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. (Nasdaq: ELAB), To File Schedule 13D Reporting 5.09% Stake in Alaunos Therapeutics, Inc. (Nasdaq: TCRT)
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB TCRT
News headline image
Northstrive Biosciences Signs Binding Term Sheet with Modulant Biosciences for Exclusive Global Animal Health Licensing of EL-22
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
RESEND - Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Announces Share Repurchases from Existing Shareholders
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with FDA for EL-22, an Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Inc. Expands Investment & M&A Efforts, Actively Seeking Acquisitions and Investments Through Strategic Sponsorship of TCA Venture Group
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Highlights Strong Capital Position: No Debt, Fully Funded, and Warrants Priced Above Market
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Inc. Announces $1.9 Million in Gross Proceeds from Warrant Inducement with Institutional Investors
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., to Present Breakthrough Muscle Preservation Asset at Exclusive UCLA Obesity Symposium
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Inc. Announces Closing of Elevai Skincare Divestiture
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
News headline image
PMGC Holdings Inc. Announces Name Change of Wholly Owned Subsidiaries
From PMGC Holdings Inc.
Via GlobeNewswire
Tickers ELAB
< Previous 1 2 3 Next >